Coatue Management’s Novavax NVAX Stock Holding History

Coatue Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$31.2M	Buy	+3,836,986	New	+$34.8M	0.11%	42
2025 Q4	–	Sell	-3,836,986	Closed	-$33.3M	–	67
2025 Q3	$33.3M	Hold	3,836,986	–	–	0.08%	54
2025 Q2	$24.2M	Hold	3,836,986	–	–	0.07%	53
2025 Q1	$24.6M	Buy	+3,836,986	New	+$31.7M	0.11%	45
2024 Q4	–	Sell	-2,224,319	Closed	-$28.1M	–	84
2024 Q3	$28.1M	Sell	2,224,319 -400,596	-15%	-$5.17M	0.1%	58
2024 Q2	$33.2M	Buy	2,624,915 +1,105,321	+73%	+$11.1M	0.13%	46
2024 Q1	$7.26M	Hold	1,519,594	–	–	0.03%	80
2023 Q4	$7.29M	Buy	+1,519,594	New	+$9.3M	0.03%	81
2023 Q3	–	Sell	-1,039,123	Closed	-$7.72M	–	96
2023 Q2	$7.72M	Sell	1,039,123 -726,936	-41%	-$5.72M	0.04%	74
2023 Q1	$12.2M	Buy	1,766,059 +1,462,000	+481%	+$13.5M	0.08%	57
2022 Q4	$3.13M	Sell	304,059 -243,496	-44%	-$4.3M	0.04%	66
2022 Q3	$9.97M	Sell	547,555 -694,161	-56%	-$30.1M	0.12%	66
2022 Q2	$63.9M	Buy	1,241,716 +358,270	+41%	+$18.6M	0.77%	31
2022 Q1	$65.1M	Buy	+883,446	New	+$78.8M	0.48%	33

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Coatue Management's NVAX Position: Q1 2026 in Review

Coatue Management opened a new position in Novavax (NVAX) in Q1 2026: 3,836,986 shares worth $31.2M. The stake represents 0.11% of the portfolio and ranks #42 among its holdings. This is a return to the name: Coatue Management previously reported a position in NVAX as recently as Q3 2025.

Coatue Management first reported a position in NVAX in Q1 2022 and has held it in 14 quarters since. The position peaked at $65.1M in Q1 2022. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

Coatue Management held 3,836,986 shares of Novavax worth $31.2M as of Q1 2026.
Novavax was a new Coatue Management position in Q1 2026.
Novavax made up 0.11% of Coatue Management's portfolio in Q1 2026, its #42 holding.
Coatue Management first reported a position in Novavax in Q1 2022 and has held it in 14 quarters since.
Coatue Management's Novavax position peaked at $65.1M in Q1 2022.
257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Coatue Management's 13F filing for Q1 2026, filed 15 May 2026.